Kwb Wealth Lexicon Pharmaceuticals, Inc. Transaction History
Kwb Wealth
- $785 Million
- Q1 2025
A detailed history of Kwb Wealth transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Kwb Wealth holds 40,640 shares of LXRX stock, worth $35,356. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,640
Previous 40,640
-0.0%
Holding current value
$35,356
Previous $30,000
23.33%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding LXRX
# of Institutions
135Shares Held
196MCall Options Held
310KPut Options Held
77.3K-
Artal Group S.A. Luxembourg, N4136MShares$118 Million100.0% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$8.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.56MShares$8.31 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY8.21MShares$7.15 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA3.69MShares$3.21 Million0.0% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $164M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...